Supplementary Table S1 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB TrialLale Erdem-Eraslan,Martin J. van den Bent,Youri Hoogstrate, Hina Naz-Khan,Andrew Stubbs,Peter van der Spek,René Böttcher,Ya Gao,Maurice de Wit,Walter Taal,Hendrika M. Oosterkamp,Annemiek Walenkamp,Laurens V. Beerepoot,Monique C.J. Hanse,Jan Buter,Aafke H. Honkoop,Bronno van der Holt,René M. Vernhout,Peter A.E. Sillevis Smitt,Johan M. Kros,Pim J. Frenchcrossref(2023)引用 0|浏览1暂无评分摘要Correlation between different platforms.更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要